2. 您的位置
3. 首页
4. 会议论文
5. A New Promising Metal-based Compound Against Breast Cancer Stem Cells: A Palladium(Ⅱ)-saccharinate C

A New Promising Metal-based Compound Against Breast Cancer Stem Cells: A Palladium(Ⅱ)-saccharinate C

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：hongqinshuling

【摘 要】

：

Palladium (Ⅱ)-based new compounds seem to have satisfactory cytotoxic activities,depending on the ligands attached.In the literature,varying ligands have already been used.

【作 者】

：

Engin Ulukaya 

【机 构】

：

Medical School of Uludag University Turkey

【出 处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年7期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Palladium (Ⅱ)-based new compounds seem to have satisfactory cytotoxic activities,depending on the ligands attached.In the literature,varying ligands have already been used.

其他文献

Chronic Lymphoid Leukemias/Lymphomas in the New Era-What is New for the Old Diseases?

Chronic lymphoid leukemia/lymphoma often presents as lymphocytosis of the peripheral blood.Morphology of the circulating leukemic/lymphoma cells provides clue to the classification of the process.

会议

Molecular Studies in Unusual Thyroid Carcinoma of Follicular Cell Origin

The presentation briefly reviews recent developments of molecular testing used in thyroid carcinoma of follicular cell origin and reports the tests used in three unusual cases,Cribriform-Morular Varia

会议

Pathologic Reporting of the Surgical Margin After Radical Prostatectomy:The Impact of Close Surgical

Positive surgical margins (PSM) after radical prostatectomy have been identified as an adverse pathological feature predictive of higher rates of biochemical recurrence,distant metastasis,and cancer-s

会议

Clinical Utility of Biomarkers for the Subclassification of Primary and Metastatic Lung Carcinomas

Fine needle aspiration (FNA) plays a critical role in the diagnosis and staging of lung carcinoma.Accurate subclassification of adenocarcinoma (ADC) and/or squamous cell carcinoma (SqCC) is crucial fo

会议

Target Discovery for Curative Precision Cancer Therapeutics

Molecularly targeted cancer therapies are designed to specifically block the drivingoncogenes that sustain tumorigenesis and tumor progression while sparing normal cells.

会议

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resis

Technology development to enable the culture of human prostate cancer (PCa) progenitor cells is required for the identification of new,potentially curative therapies for PCa.

会议

A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies i

Background: Patient-tailored therapy based on tumor genomics is a promising tool in cancer therapy.However,in current practice it is limited to 30-40% of the patients whose tumor harbor actionable DNA

会议

Targeted Enzyme Therapy (TET): A Novel Tumor-directed Enzyme Prodrug Therapy

Gene therapy is an attractive approach for the treatment of cancer because of its ability to localize toxicity to tumor cells.Following delivery of the suicide gene to target cells,an inactive prodrug

会议

Amino Acid Transporters as a Novel Class of Drug Targets for Cancer Therapy

Tumors alter metabolic pathways to meet their increasing anabolic requirements.Enhanced cell proliferation places an increased demand for nutrients.

会议

Cancer Molecular Clock Reveals Novel Opportunities for Anticancer Drug Discovery

Disruption of the circadian clock is associated with a variety of human pathologies,including cancer.Rather than being a mere consequence of a global changes associated with the cancer cell transcript

会议